Market Place
Sourcing Support
All News #Library
Biotech
Artios` Phase 2A Study: Alnodesertib Combo Hits Primary Endpoint
02 Mar 2026 //
GLOBENEWSWIRE
FDA Fast-Tracks Artios` ART6043 for gBRCA+ HER2- Breast Cancer
23 Feb 2026 //
GLOBENEWSWIRE
Artios To Present At J.P. Morgan Healthcare Conference
07 Jan 2026 //
GLOBENEWSWIRE
Artios Secures $115M Series D To Advance Clinical Programs
17 Nov 2025 //
GLOBENEWSWIRE
Artios Unveils ART6043 Phase 1/2A Data At ESMO Congress 2025
17 Oct 2025 //
GLOBENEWSWIRE
Artios To Present Phase 1/2A Data For Pol? Inhibitor ART6043
13 Oct 2025 //
GLOBENEWSWIRE
Artios Gets Fast Track For Alnodesertib In ATM-neg mCRC Cancer
24 Sep 2025 //
GLOBENEWSWIRE
Artios Pharma Details Presentations at AACR Annual Meeting 2025
15 Apr 2025 //
GLOBENEWSWIRE
Artios Pharma to Present at 43rd J.P. Morgan Healthcare Conference
19 Dec 2024 //
GLOBENEWSWIRE
Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD
09 Apr 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.